Students share findings from the frontiers of biomedical research

October 10, 2009

Doha, October 7, 2009 -Members of Qatar's research and medical community recently gathered at Weill Cornell Medical College in Qatar to learn more about research conducted by the college's pre-medical and medical students. The sixth annual Medical Student Research Forum not only highlighted the latest findings, but also gave 25 WCMC-Q students a chance to participate in a vital part of the research process: explaining findings with the larger scientific community.

Presentations highlighted work done by students chosen for their exceptional performance to participate in the college's annual Summer Research Program. Through the program, they experienced an eight-week immersion into laboratories at WCMC-Q, Weill Cornell Medical College in New York City and Cornell University in Ithaca. Their presentations--a third of which were presented through lectures and the remainder through scientific posters--represent the leading edge of investigation into conditions affecting countless people around the world.

"The research program advances critical thinking and problem solving skills in the students who participate," said Khaled Machaca, PhD, associate dean for research at WCMC-Q. "The work they do every day in the lab highlights basic science that is fundamental to the field of medicine and this is why the experience is essential, he continued."

Guests heard student lectures about research involving microbiology, genetics, stem cells, with study directed at ovarian cancer, H1N1, defects in nerve tissue, reproductive cell stages and preeclampsia--a condition where high blood pressure develops during pregnancy--among other conditions.

"Students at this forum have worked on a wide range of the studies with some of the most advanced research teams and methods available in the world today," said Dr. Javaid Sheikh, interim dean of WCMC-Q. "This experience, at such an early stage in their careers, ensures the students' deeper understanding about the importance of research and ignites a passion in some to devote themselves to it in the future. This is all part of creating a biomedical research culture here in Qatar over the generations."

After the lectures, the audience moved into the open hallways to browse through poster presentations of research and discuss findings with the students. Examples included the effects of the western diet; genetic expression that can predict cancer; biological markers that could signal Parkinson's disease and genes related to prostate cancer among other lines of inquiry.

"I had the chance to work in a brand new field of cancer research that hasn't even been published yet," said Utsav Nandi, a second-year medical student, who worked with Vivek Mittal, principal investigator at the Department of Cardiothoracic Surgery at Weill Cornell University Medical Center, New York, to explore a genetic fragment that was recently discovered to play a role in cancer metastasis. "This experience--of learning new genetic research techniques and practicing them repeatedly to get results--was extremely valuable to me."

"I'm proud of the results of the study I was working on," said Fadwa Fares, a first-year medical student who worked on a project involving ovarian tumor cells' resistance to heat therapy. Working in the WCMC-Q stem cell lab, under the guidance of Dr. Arash Rafii Tabrizi, head of stem cell research and assistant professor of genetic medicine, Fares helped discover a key factor that affects cancer cells response to therapy. "I hope that once they validate these results, we can apply them to ovarian cancer therapy and improve the technique."

Established in partnership with Qatar Foundation, WCMC-Q is part of Weill Cornell Medical College of Cornell University, the first US institution to offer its MD degree overseas. WCMC-Q shares the triple mission of Weill Cornell Medical College: a dedication to excellence in education, patient care, and biomedical research.

WCMC-Q offers an innovative educational program that includes a three-year Pre-medical Program followed by a four-year Medical Program with teaching by Cornell faculty. Each program has a separate admission process guided by the standards of admission in use at Cornell University in Ithaca and its Medical College in New York City.

Faculty and staff of WCMC-Q and Weill Cornell in New York City are building the research capacity of Qatar in partnership with Qatar Foundation, Sidra Medical and Research Center, Hamad Medical Corporation, the Ministry of Health and other organizations. WCMC-Q's program focuses on high quality research in genetic and molecular medicine, women's and children's health, gene therapy, and vaccine development.


About Qatar Foundation

Founded in 1995 by decree of His Highness Sheikh Hamad Bin Khalifa Al Thani, Emir of Qatar, Qatar Foundation is a non-profit organization focusing on education, scientific research and community development. Under Qatar Foundation's umbrella are Education City, which comprises elite universities, several academic and training programmes and Qatar Science and Technology Park, which boasts more than 21 world class companies involved in scientific research and development.

Chaired by Her Highness Sheikha Mozah bint Nasser Al Missned, Qatar Foundation also aims to enhance lives through community development initiatives including Doha Debates, Reach out To Asia and Al Jazeera Childrens Channel.

Joint venture partnerships in the areas of design, ICT, telecommunications, policy studies and event management contribute to fulfilling the objectives of Qatar Foundation.


Weill Cornell Medical College-Qatar

Related Ovarian Cancer Articles from Brightsurf:

Ovarian cancer cells cooperate to metastasize
In a study on human ovarian cancer cells in mice, Harvard Medical School researchers discovered a transient, cooperative interaction between cell subpopulations that allows otherwise nonmetastatic tumor cells to become aggressive and spread.

Photodynamic therapy used to treat ovarian cancer
Photodynamic therapy (PDT) is one of the most promising methods of treating localized tumors.

Studying the development of ovarian cancer with organoids
Researchers from the group of Hans Clevers at the Hubrecht Institute have modeled the development and progression of high-grade serous ovarian cancer in mini-versions, or organoids, of the female reproductive organs of the mouse.

New class of drugs could treat ovarian cancer
A team of researchers across the University of Manchester have shown that a new class of drugs are able to stop ovarian cancer cells growing.

How to catch ovarian cancer earlier
Ovarian cancer is often diagnosed too late for effective treatment.

New compound could help treat ovarian cancer
Scientists from the University of Sheffield have discovered a compound that could be more effective in treating certain cancers than standard chemotherapy.

Epigenetic markers of ovarian cancer
Insilico Medicine and its collaborators from Johns Hopkins and Insilico Medicine, used an integrated approach by coupling identification of genome-wide expression patterns in multiple cohorts of primary ovarian cancer samples and normal ovarian surface epithelium with innovative computational analysis of gene expression data, leading to the discovery of novel cancer-specific epigenetically silenced genes.

Ovarian cancer statistics, 2018
A new report from the American Cancer Society provides an overview of ovarian cancer occurrence and mortality data.

Ovarian cancer drug shows promise in pancreatic cancer patients with BRCA mutation
A targeted therapy that has shown its power in fighting ovarian cancer in women including those with BRCA1 and BRCA2 mutations may also help patients with aggressive pancreatic cancer who harbor these mutations and have few or no other treatment options.

TGen-led study finds potent anti-cancer drug effect in rare ovarian cancer
An anti-cancer drug used to fight leukemia shows promise against a rare and aggressive type of ovarian cancer -- small cell carcinoma of the ovary hypercalcemic type (SCCOHT) -- which strikes young women and girls, according to a study led by the TGen.

Read More: Ovarian Cancer News and Ovarian Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to